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1. Introduction 
In Poland, the number of new installations of FFDM (Full – Field Digital Mammography) 
units is increasing every year. These increasing numbers of digital mammography systems 
(DR systems) were possible to be evaluated on the basis of the data provided by the facilities 
taking part in the mammography screening program organized by the Polish Ministry of 
Health. 
In 2006, in the framework of the “Polish National Breast Cancer Early Detection Program for 
Women aged from 50 to 69” was initiated. In order to create a structure for administration of 
the screening program of the Ministry of Health, 16 regional Coordination Centres, covering 
the administrative regions of the country, were created. Also, a Central Coordination 
Centre, located at the Centre of Oncology in Warsaw was set up. Thanks to such 
organization it was possible to contact all mammography facilities involved in the screening 
program, to receive the necessary data from them and to evaluate their equipment. 
Furthermore, it was possible to curry out control of physical and technical parameters of the 
mammography equipment and to collect data concerning the individual woman exposures. 
The data, in the range necessary to calculate the doses received by the women during the 
examinations were collected. On this basis it was possible to evaluate that in 2007 in the 
whole country there were 320 mammography units used in the mammography screening 
program, and among them there were only 5 DR systems. On the other hand in 2010 and in 
2011 only in the Mazovia region the screening was carried out with 7 (out of 48) and 9 (out 
of 51) DR mammography systems respectively. Two of them were installed at the Centre of 
Oncology in Warsaw. However, the increase of the DR systems in Poland is limited by the 
relatively high costs of such installations as compared with the screen – film mammography 
systems (SFM systems). Moreover, the facilities equipped with mammography systems 
complying with the quality control requirements, are replacing SFM systems with computed 
radiography systems (CR systems). 
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The literature data indicate the evident advantages of the application of digital detectors in 
mammography. Apart from advantages linked with much simpler procedures of computer 
systems as far as processing, presentation, archiving and transmission of digital images are 
concerned there are more important advantages of DR systems over SMF systems namely: 
better image quality and lower doses of radiation received by the examined women. 
According to the published data (Gennaro, 2004, 2006; Gosch, 2006; Hermann, 2002; 
Lawinski, 2008) the average glandular doses are within 2.0 mGy per exposure allowing for 
detection of the objects of 0.1 mm diameter which is very satisfying. However, the results of 
some authors (Fischmann et al., 2005) indicate that the doses received by women examined 
with the systems equipped with digital detector are higher than those when the screen - film 
detector is used. These discrepancies in the results called for further analysis of absorbed 
doses and image quality in mammography with DR systems. The authors of this chapter 
analysed and evaluated the values of absorbed doses received by women undergoing 
screening mammography examinations at 8 facilities in Poland equipped with DR systems 
from 4 different manufacturers. This made possible a comparison of the performance of 
different DR systems as far as image quality is concerned.  
2. Doses in mammography 
2.1 Average glandular dose 
According to “Dosimetry in Diagnostic Radiology: An International Code of Practice” by 
International Atomic Energy Agency the average glandular dose (later called AGD) is the 
mean absorbed dose in the glandular tissue (excluding skin) in a uniformly compressed 
breast. The absorbed dose is the mean energy imparted to matter of mass. The unit of 
absorbed dose is gray (Gy). 
The higher the AGD value the higher the probability of inducing a cancer in examined 
women. It is especially important in case of mammography screening when probably 
healthy women are examined. For this reason the determination of this dose is one of the 
elements of quality control of the mammography equipment. The direct determination of 
the AGD is rather impossible, therefore it is determined in practice by the multiplication of 
the air kerma at the upper surface of the breast (without taking into account the scattered 
radiation) by the appropriate conversion factors according to the following formula: 
 AGD = Kgcs  (1) 
where: 
AGD – average glandular dose, in mGy; 
K - entrance surface air kerma (ESAK), in mGy; 
g – factor taking into account breast thickness after compression, dependent on the half 
value layer of the X-ray beam;  
c – factor taking into account the breast tissue composition, dependent on the  half value 
layer of the X-ray beam and on the breast  thickness after compression; 
s – factor taking into account the X–ray spectrum, dependent on the anode material and on 
the additional filter.   
The values of the above mentioned factors have been calculated by Dance using Monte 
Carlo methods for simple breast model and various X–ray spectra in mammography. They 
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were presented, in the form of tables, in “Additional factors for the estimation of mean 
glandular breast dose using the UK mammography dosimetry protocol” by Dance et al. In 
this paper it was assumed that the breast tissue composition is dependent on the breast 
thickness after compression according to the following formula: 
 y = t3 + t2 + t +    (2)  
where: 
y – glandular tissue content of the breast, in %; 
t - breast thickness after compression, in mm; 
, , ,  – coefficients dependent on the age of women in two age groups:  40 -  49 years and 
50 - 64 years, given in Table 1.  
 
Coefficient Age 40 to 49 Age 50 to 64 
 0,00005209 -0,0001118 
 0,00125494 0,03932 
 -1,988 -4,544 
 138,8 176,0 
Table 1. Coefficients for polynomial fit of glandularity of breast, dependent on the age of 
women in two age groups:  40 -  49 years and 50 - 64 years (according to “Additional factors 
for the estimation of mean glandular breast dose using the UK mammography dosimetry 
protocol”). 
The above mentioned method of AGD determination is limited to the central part of the 
breast above the ionization chamber of the Automatic Exposure Control (AEC) system (in 
the SFM systems) and above the main region of detector of the AEC system (in DR systems). 
The measurement of ESAK during the exposure requires the use of very small detectors 
such as thermoluminescence dosimeters which would be visible on mammography images. 
However, the thermoluminescence dosimeters require complicated and well calibrated 
read-out systems. Simpler method of determining of the ESAK, not influencing the 
mammography image, is the measurement of the dose with a dosimeter of larger 
dimensions than the TLDs at the tube voltage (in kV) and a combination of anode/filter 
(such as for the breast exposure during examination) with arbitrary tube load (in mAs) and 
focus-dosimeter distance. Subsequently, assuming the linear dependence of dose in air on 
tube load and inverse dependence on focus-detector distance squared, it is possible to 
calculate the ESAK on the basis of the measured dose for an exposure of the breast of 
determined thickness after compression and taking into account the parameters of the 
exposure. Therefore, in order to calculate the doses received by women during 
mammography examinations the following parameters have to be known: anode/filter 
combination, tube voltage, tube load, breast thickness after compression, and also the 
woman age. Subsequently, the measurements of the half-value layer and the air kerma for 
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every tube voltage value and anode/filter combination used during examinations should be 
performed. On the basis of gathered data and performed measurements the values of AGD 
for single exposure for individual woman may be determined, later called the clinical breast 
dose. 
For the maximal uncertainty of the AGD determination a value of 14% suggested in the 
„Patient dose in digital mammography” by Chevalier et al. may be adopted. 
2.2 Doses for typical breast 
According to „European guidelines for quality assurance in breast cancer screening and 
diagnosis Fourth edition” by European Commission, in the frame of quality control tests the 
AGD values for typical breast, simulated by the homogenous PMMA plates should be 
determined. The PMMA plates from 2.0 cm to 7.0 cm thick are equivalent to typical breast 
from 2.1 cm to 9.0 cm thick, as it is shown in Table 2. During the quality control tests the 
exposures of PMMA plates should be performed with the same settings as during the 
clinical exposures (the same choice of the AEC mode, the same choice of the anode and 
additional filters, the same exposure control step). Subsequently, the AGD values for the 
different PMMA thicknesses exposures should be determined as for the exposure of 
equivalent breast (as described in 2.1 above). The AGD values obtained in such way may be 
compared to the limiting values. In Table 2, two types of such limiting values are listed for 
various PMMA thicknesses and equivalent breast thicknesses after compression. The first 
one, acceptable level, is a minimum requirement which has to be fulfilled by every 
mammography system. The second one, achievable level, more restrictive, should be the 
aim to attain by every mammography facility. 
 
 
PMMA thickness 
[cm] 
Equivalent breast 
thickness 
[cm] 
Maximum AGD for equivalent breast [mGy] 
Acceptable level Achievable level 
2.0 2.1 < 1.0 < 0.6 
3.0 3.2 < 1.5 < 1.0 
4.0 4.5 < 2.0 < 1.6 
4.5 5.3 < 2.5 < 2.0 
5.0 6.0 < 3.0 < 2.4 
6.0 7.5 < 4.5 < 3.6 
7.0 9.0 < 6.5 < 5.1 
 
Table 2. AGD limiting values for equivalent breast thicknesses according to “European 
guidelines for quality assurance in breast cancer screening and diagnosis Fourth edition”. 
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2.3 Clinical breast doses 
The authors of this chapter had an opportunity to determine the AGD values for exposures 
of individual women (clinical breast doses). These doses were determined for women 
examined with 10 mammography units equipped with full-field digital detectors (DR 
systems), installed at facilities taking part in the screening program in Poland.  
Determination of the clinical breast doses required the collection of all exposure parameters 
for examined women. The collected data included the following parameters: anode material, 
additional filter type, tube potential value, tube load value, birth year of a woman and 
breast thickness after compression. For every mammography unit the data for 200 exposures 
(examination of 50 women) were collected.  Subsequently, for every mammography unit the 
measurements of air kerma were performed (taking into account the linear dependence of 
air kerma on tube load) and also the measurement necessary for determination of half value 
layer for all tube potential values used during the exposures. The measurement were 
performed with a multimeter Piranha from RTI Electronics AB (type: 305; uncertainty: ± 5%) 
and with aluminium filters from Gammex (6x: 0.10 mm thickness and Al purity ≥ 99.9%). 
According to the methodology described in 2.1 above, the AGD values were calculated for 
every exposure.  In this way the values of clinical breast doses were determined for 500 
women (2000 exposures).  
Subsequently, the estimated values of clinical breast doses for each exposure were compared 
to the levels listed in Table 2. To determine the clinical breast dose limit for each breast 
thickness after compression the second-degree polynomial, based on data contained in Table 
2, was fitted. The polynomial for acceptable level is given by the formula (3), and for the 
achievable level by the formula (4):  
 y = 0.091x2 – 0.2326x + 1.1786   (3) 
 y = 0.059x2 – 0.012x + 0.402   (4) 
where: 
y – the clinical breast dose limit for each breast thickness, in mGy; 
x – breast thickness after compression, in cm. 
The correlation coefficient R2 between the values given by the above formulas and the values 
listed in Table 2 was higher than 0.99 in every case.  
In Table 3, for each of 10 DR systems (from 4 manufacturers indicated by consecutive 
numbers) the following parameters are given: material of image detector, the percentage of 
exposures performed with given anode/filter combination, the percentage of exposures for 
which the clinical breast doses did not exceed the acceptable an achievable limits. The 
presented results indicate that the maximal percentage of exposures for which clinical breast 
doses met the acceptable and achievable limits for DR systems for which all exposures were 
performed with the W/Rh combination. However, the case of the mammography unit 8 
does not confirm it. Furthermore, the analysis of the results of mammography units 2, 3, 6, 8 
(from the same manufacturer) indicate that the doses received by the women depend not 
only on the type of the unit and the manufacturer of the unit but first of all on that how the 
particular mammography system was calibrated by manufacturer service. 
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Unit number/ 
manufacturer 
number 
Material of 
image detector 
The percentage 
of total 
numbers of 
exposures with 
given 
combination 
anode / filter 
[%] 
The 
percentage of 
exposures not 
exceeding 
acceptable 
level 
[%] 
The 
percentage 
of exposures 
not 
exceeding 
achievable 
level 
[%] 
Unit 1 / 
Manufacturer 1 
amorphous 
selenium 
100.0 (W/Rh) 99.0 89.0 
Unit 2 / 
Manufacturer 2 
amorphous 
selenium 
84.0 (Mo/Mo) 
16.0 (Mo/Rh) 
49.0 32.0 
Unit 3 / 
Manufacturer 2 
amorphous 
selenium 
7.5 (Mo/Mo) 
92.5 (Mo/Rh) 
80.5 47.0 
Unit 4 / 
Manufacturer 3 
amorphous 
selenium 
100.0 (W/Rh) 92.0 85.5 
Unit 5 / 
Manufacturer 4 
amorphous 
silicon 
1.0 (Mo/Mo) 
15.0 (Mo/Rh) 
84.0 (Rh/Rh) 
80.0 52.5 
Unit 6 / 
Manufacturer 2 
amorphous 
selenium 
50.5 (Mo/Mo) 
49.5 (Mo/Rh) 
76.5 57.0 
Unit 7 / 
Manufacturer 1 
amorphous 
selenium 
100.0 (W/Rh) 99.5 97.0 
Unit 8 / 
Manufacturer 2 
amorphous 
selenium 
64.5 (Mo/Mo) 
35.5 (Mo/Rh) 
97.5 92.05 
Unit 9 / 
Manufacturer 3 
amorphous 
selenium 
100.0 (W/Rh) 100.0 100.0 
Unit 10 / 
Manufacturer 3 
amorphous 
selenium 
100.0 (W/Rh) 100.0 99.0 
Table 3. Material of image detector, the percentage of exposures performed with given 
anode/filter combination, the percentage of exposures for which the clinical breast doses 
did not exceed the acceptable and achievable limits for 10 DR systems. 
The results of clinical breast dose calculated for 10 mammography units equipped with DR 
systems are presented in Fig. 1. in a form of a histogram in grey. These dose values range 
from 0.12 mGy to 5.80 mGy with the mean value of 1.78 mGy. They do not exceed the limit 
values for typical breasts at the acceptable level in 87.4% of cases and at the achievable level 
in 65.2% of cases. For comparison, in Fig. 1 a histogram, in black, of clinical breast doses 
calculated for 50 women examined with the use of one SFM unit is presented. This 
mammography unit was installed in the Coordination Centre of the Screening Program in 
Poland in 2007. The mammography unit and the accessories (film processor, viewing box, 
amplifying screens and films) were of good quality. They were systematically controlled 
and fulfilled all quality criteria given in „European guidelines for quality assurance in breast 
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cancer screening and diagnosis Fourth edition”. The clinical breast dose values determined 
for the SFM unit ranged from 0.40 mGy to 4.22 mGy with the mean value of 1.68 mGy. They 
did not exceed the limit values for typical breasts at the acceptable level in 98% of cases and 
at the achievable level in 95% of cases.  
The comparison of two histograms in Fig. 1 shows that the frequently cited opinion that the 
women examined with the use of DR mammography systems receive smaller doses of 
radiation than the women examined with SFM systems is not generally true. Furthermore, 
the SFM system presented here generated small clinical breast doses with simultaneous 
fulfilling the quality requirements formulated by the „European guidelines for quality 
assurance in breast cancer screening and diagnosis Fourth edition”. 
 
Fig. 1. The histograms of the clinical breast doses received by the women examined with the 
use of ten mammography units equipped with DR systems (in grey) and received by the 
women examined with the use of one SFM unit (in black).  
2.4 The modifications in DR systems and the clinical breast doses 
During the exploitation of the DR systems the manufacturer service upgrades the software 
of mammography unit, performs the calibration of the image detector and, in particular 
situations, replaces the image detector. Upgrade of the mammography unit software means 
changes of AEC area setting, exposure parameters setting and calibration setting. The 
replacement of the image detector is associated with the calibration of new image detector. 
All these activities should not influence the dose received by the examined women. 
However, the authors of this chapter noticed that the service actions in this area result in the 
increase of the clinical breast doses. For three mammography units (units 2, 3 and 4 are the 
same as in Table 3) the manufacturer service performed alterations of the image detector 
and the mammography system software. For the mammography units 2 and 3 the clinical 
breast doses were recalculated three times: directly after the installation of mammography 
unit, after the replacement of the image detector and the upgrade of the software, and for 
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the mammography unit 4 twice: after the installation of mammography unit and before the 
calibration of the image detector. The data concerning the minimum, maximum and mean 
values for established clinical breast doses and the percentage of exposures meeting the 
acceptable and achievable limits are presented in Table 4. 
The data analysis indicate that the mean values of clinical breast doses for the 
mammography unit 3 after the replacement of the image detector and after the upgrade of 
the software increased by about 44% and 50% in the relation to the mean value of clinical 
breast doses determined after installation of mammography unit. At the same time the 
number of exposures meeting the acceptable limit diminished from 22% to 1% and those 
meeting the achievable limit from 1% to 0%. In the case of the mammography unit 2 the 
mean clinical breast dose value after the upgrade of the software decreased by about 4% as 
compared to the mean value of clinical breast dose determined after the installation of the 
unit. On the other hand, after the replacement of the image detector mean value of the 
clinical breast dose increased by 8% in relation to the mean value of clinical breast doses 
calculated after the installation of the unit. The percentage values of exposures fulfilling the 
acceptable limits decreased after consecutive changes from 66% to 38% and 23% and for the 
achievable limits from 41% to 13% and 12%. For mammography unit 4 the mean value of 
clinical breast doses before the calibration of the image detector increased by about 9% in 
relation to clinical breast doses established just after the installation of the mammography 
unit and the small decrease of the number of exposures meeting the acceptable and 
achievable limits was observed.  
Taking into account the three DR systems, two from the same manufacturer, it is possible to 
conclude that during the upgrade of the software, calibration and exchange of the image 
detector (made by the manufacturer services) changes are introducing which, as a 
consequence, induce increase of the doses received by the women during examinations 
(which was observed in the case of the mammography unit 3). The manufacturer service 
staff claimed that they were carefully following the manufacturer indications. It might 
suggest that these were minimal indications, which leave a lot of freedom in service 
activities. Therefore, it is reasonable to determine the clinical breast doses values after every 
manufacturer service intervention into the software and the image detector in order to be 
able, in case of increased doses, to optimize the exposure parameters.  
Monitoring of the doses received by the women during mammography examinations, 
especially during screening, is necessary in order to protect potentially healthy population 
against additional irradiation. The values of AGD, calculated by the DR systems after every 
exposure and displayed on every mammography image would help the task. The accuracy 
of these values was tested during the clinical breast dose determination for the cases 
described above. For every exposure, the displayed AGD values were compared with 
clinical breast doses values calculated on the basis of exposure parameters. The percentage 
of the cases when the displayed AGD value agreeded with calculated one was established. 
As the criterion of the agreement between displayed and calculated values it was adopted 
that differences between these values could not be bigger than ±14% of calculated clinical 
breast doses values (i.e. the uncertainty of clinical breast dose value determination). The 
results of the comparisons are presented in Table 4. They indicate the discrepancies between 
the displayed and calculated values. The best agreement, for 71%exposures, was for 
mammography unit 2 just after its installation. The actions of manufacturer service resulted 
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Table 4. The values of clinical breast doses (minimal, maximal and mean), percentage of 
exposures fulfilling acceptable and achievable limits of doses, percentage of calculated 
clinical breast doses values complied with AGD values displayed after exposure and 
percentage of exposures for which displayed values were lower than calculated values, after 
consecutive alterations introduced by the manufacturer service in three DR mammography 
systems (units 2, 3 and 4 are the same as in Table 3). 
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in diminishing of this agreement in every case. Additionally, in the majority of cases the 
displayed doses were lower than the calculated ones. It was not possible to establish the 
reason of such discrepancies between the displayed values and the values calculated 
according to recommendations of the „European guidelines for quality assurance in breast 
cancer screening and diagnosis Fourth edition”. In any case, the displayed values could not 
be used for the evaluation of the radiation doses received by the examined women. 
3. Optimization of exposure parameters  
The significant increase of clinical breast dose values after the intervention of manufacturer 
service in mammography unit 3 (Table 4) forced the authors of this chapter into the attempt 
of exposure parameters optimization in order to reduce the doses received by the examined 
women. However, such dose reduction should not affect the image quality and the 
functioning of the automatic exposure control (AEC) system. The main parameter of image 
quality is the visibility of very small objects at the contrast threshold level. The functioning 
of AEC system is evaluated by a parameter linked to contrast handling by the system. This 
parameter is called the contrast to noise ratio (CNR) calculated for the objects of various 
thicknesses simulating typical breasts. 
3.1 Contrast threshold level of the image  
In mammography it is important to visualize and distinguish objects of low contrast and small 
dimensions on the image. The threshold contrast visibility is determined for circular objects of 
diameters from 0.1 mm to 2.0 mm placed in the homogenous PMMA plates of 4.5 cm total 
thickness. The small objects are made of gold, and the radiation contrast variability is attained 
by their various thicknesses. One of the phantoms suitable for contrast threshold 
determination is the CDMAM phantom manufactured by Artinis (Fig. 2). This phantom is 
composed of an aluminium plate type Al 1050 (99.5% purity) of 0.5 mm thickness with 
embedded golden discs (Au 99.9999 purity) of various thicknesses (from 0.03 m to 2.00 m) 
and various diameters (from 0.06 mm to 2.00 mm). The golden discs are placed in a matrix of 
16 lines and 16 columns which is turned by 45 in relation to the phantom longer side (in order 
to minimize the so called heel-effect1 on the image quality). Every matrix element contains two 
identical discs, one in the middle of the element and the other one in one of the corners of the 
element. The reason of the placement of the second disc in an arbitrarily selected corner is to 
not allow the observer analysing the images to memorize the disc positions. The aluminium 
plate is placed in the homogenous PMMA plate of 0.5 cm thickness. In the phantom set there 
are additional four PMMA plates (each 1.0 cm thick). The phantom dimensions are adapted to 
the dimensions of the standard mammography films (18 cm x 24 cm). 
According to the recommendations of the manufacturer of the CDMAM phantom (“Manual 
Contrast Detail Phantom CDMAM 3.4. & CDMAM Analyser software V1.2.”) the evaluation 
of objects visibility should be done on the basis of the analysis of the unprocessed (by 
mammography system software) image. On this kind of image (Fig. 3a) the observer is not 
able to detect any object, even the largest discs of 2.0 mm diameter. For comparison, in 
                                                 
1 Heel – effect: The non-uniform distribution of air kerma rate and of the beam hardness in an X-ray 
beam in planes perpendicular to the beam axis and in the direction cathode to anode (according to 
“Dosimetry in Diagnostic Radiology: An International Code of Practice” by International Atomic 
Energy Agency). 
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Fig. 3b the processed (by mammography system software) CDMAM phantom image is 
presented. 
 
Fig. 2. CDMAM phantom manufactured by Artinis. 
  
Fig. 3. Unprocessed image (a) and processed image (b) of CDMAM phantom for 
mammography unit 10 (unit 10 is the same as in Table 3).  
              a       b 
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The unprocessed image is transferred from workstation of mammography unit to the separate 
computer software provided by the manufacturer of the CDMAM phantom (i.e. CDMAM 
Analyser software) in order to analyse this image. Thicknesses of the objects of worst visibility for 
every object diameter are the final result of the computer analysis. As an example, in Table 5 the 
results of the image computer analysis for one of the DR systems are presented. Diameters 
of the objects are given in mm and thicknesses of the objects are given in m. 
 
Diameter: 0.060 0.080 0.100 0.130 0.160 0.200 0.250 0.310 0.400 0.500 0.630 0.800 1.000 1.250 1.600 2.000 
Thickness: 2.500 0.992 0.525 0.429 0.334 0.152 0.125 0.079 0.067 0.068 0.038 0.030 0.030 0.030 0.030 0.040 
Table 5. The results of the image analysis with CDMAM Analyser software V1.2. 
In order to get reliable results at least eight images should be analysed. In Fig. 4 the Contrast 
Detail Curves for a single image and for eight images are presented. It may be easily notice 
that the curves differ considerably, especially for discs of 0.13 mm and of 1.00 m diameter. 
The analysis of larger number of images is necessary to avoid random errors.  
 
Fig. 4. Contrast Detail Curves for a single image (left) and for eight images of the same series 
(right) for mammography unit 2 (unit 2 is the same as in Table 3). 
The CDMAM Analyser software does not provide the contrast values for structures 
contained in the CDMAM phantom. Therefore the next step after the plotting of the 
Contrast Detail Curve is to determine the threshold contrast on the basis of determined 
object thicknesses. The threshold contrast values of the object for several selected 
thicknesses are given in the “European guidelines for quality assurance in breast cancer 
screening and diagnosis Fourth edition”. These values were calculated for X-ray spectrum 
of 28 kV, molybdenum anode and additional filtration of 0.03 mm Mo on the basis of the 
data from the „Catalogue of diagnostic X – ray spectra & other data” (IPEM report 78) 
published by the  British Institute of Physics and Engineering in Medicine. In digital 
mammography various anode/filter combinations are employed, different from Mo/Mo, 
for example W/Rh (Table 3), and therefore the X-ray spectra differ considerably (for 
example the HVL) from the Mo/Mo spectrum at 28 kV. In theory, the data contained in 
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the „Catalogue of diagnostic X – ray spectra & other data” may be used for calculation of 
contrasts for different spectra. The software included in the catalogue allows for the 
generation of pre-attenuated spectra with additional filtration, and for calculation of tube 
output for such spectra (expressed as air kerma value per tube load value at 75 cm distance 
from the focal spot). The CDMAM phantom, with 4.0 cm of PMMA added, can be here 
treated as an additional filter consisting of 4.3 cm of PMMA, 0.5 mm aluminium, and 0.03-
2.00 μm of gold. Only the phantom is taken into account, attenuation caused by elements 
of the mammography unit (compression plate, breast support table, anti scatter grid, etc) 
is omitted. The radiation contrast can be defined as the percentage difference between the 
intensity of the beam passing through the phantom with a structure and beam passing 
through the phantom without the structure. However, the „Catalogue of diagnostic X – 
ray spectra & other data” contains only a limited range of spectra.  The spectra for 
molybdenum and rhodium targets are available for tube voltage values from 25 kV to 
32 kV, and spectra for a tungsten target are only available for tube voltage values from 
30 kV to 150 kV, while in mammography the tube voltage values beyond these ranges are 
also used.  Beam spectra for all target materials and wider range of tube voltage values (18 
kV to 40 kV) can be generated using polynomial models (“Molybdenum, rhodium, and 
tungsten anode spectral models using interpolating polynomials with application to 
mammography”). An Excel spreadsheet was written that generates such spectra, 
calculates their attenuation by filter material (e.g., Mo or Rh) and by the CDMAM 
phantom (similarly as in the software included with IPEM report 78), and calculates 
radiation contrast of the structures. Linear attenuation coefficients and photon to 
kerma-in-air conversion factors taken from „Catalogue of diagnostic X – ray spectra & 
other data” are used in the calculations. The spreadsheet allows the user to calculate 
radiation contrast for virtually any beam quality used in digital mammography. 
In Table 6, the values of threshold contrast in the case of the exposures at W/Rh 
combination of the CDMAM phantom for mammography units 4 and 10 are presented. The 
contrast values for the phantom structures were calculated following two methods. In the 
first one the catalogue of spectra from IPEM report 78 was used and adopted the same 
spectrum (Mo/0.03 mm Mo, 28 kV) as per „European guidelines for quality assurance in 
breast cancer screening and diagnosis Fourth edition”. In the second one the contrast was 
calculated for the actual spectrum, in this case the W/0.05 mm Rh and 28 kV with the use of 
the above described spreadsheet. For both mammography units the contrast values 
determined for beam Mo/0.03 mm Mo, 28 kV are higher than to the contrast values for the 
actual beam. It shows that the differences of 26% - 27% in calculation of threshold contrast 
exist for both methods for all diameters and thicknesses values. It must be taken into 
account during the evaluation of quality control tests and all kinds of comparisons. It may 
be expected that the differences of threshold contrast values may be larger if the tube 
voltage value of the actual spectrum differs from 28 kV.  
The values of the threshold contrast cannot exceed the limits given in the „European 
guidelines for quality assurance in breast cancer screening and diagnosis Fourth edition”. 
For every object diameter two limits were set up (acceptable and achievable) expressed by 
the thickness of the object and by the corresponding threshold contrast (Table 7). These 
limits were established with the use of the CDMAM phantom placed between two PMMA 
plates of 2.0 cm thick and for typical X-ray spectrum for tube voltage value 28 kV, 
molybdenum target material and 30 µm thick molybdenum filter. 
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Table 6. Values of the threshold contrast for the exposures at the W/Rh combination of the 
CDMAM phantom, determined with two methods for mammography unit 4 and 10 (units 4 
and 10 are the same as in Table 3). 
μ 
μ 
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Diameter of 
detail 
[mm] 
Acceptable value Achievable value 
gold thickness 
[m] 
threshold 
contrast [%] 
gold thickness 
[m] 
threshold 
contrast [%] 
0.10 1.68 23.00 1.10 15.80 
0.25 0.352 5.45 0.244 3.80 
0.50 0.150 2.35 0.103 1.60 
1.00 0.091 1.40 0.056 0.85 
2.00 0.069 1.05 0.038 0.55 
Table 7. Limiting values (acceptable and achievable levels) of the thickness of gold objects 
and corresponding value of threshold contrast for discs diameters from 0.10 mm to 2.00 mm 
according to the „European guidelines for quality assurance in breast cancer screening and 
diagnosis Fourth edition”. 
In Table 8 the examples of the image quality evaluation for four DR mammography units 
are presented. For the structures of the largest diameter (2.00 mm) on all images the 
structures of the same thicknesses were visible. The largest differences between the 
mammography units were seen for the low contrast objects of the smallest dimensions. 
While comparing the results of the analysis with the criteria given in the „European 
guidelines for quality assurance in breast cancer screening and diagnosis Fourth edition” 
(Table 7) one should consider mainly the visibility of the objects of specified thickness and 
not the specified contrast. The radiation contrast depends on the radiation quality used and 
does not characterize specifically the actual structure but the structure imaged with a given 
radiation beam. On the other hand the size of the structures visible on the phantom image is 
directly linked to the size of structures visible on the breast image.  
 
Unit 
number 
Parameter 
Diameter of detail [mm] 
0.10 0.25 0.50 1.00 2.00 
2 
Gold thickness [m] 0.522 0.097 0.060 0.030 0.040 
Threshold contrast [%] 8.74 1.69 1.05 0.53 0.70 
3 
Gold thickness [m] 0.806 0.143 0.056 0.036 0.040 
Threshold contrast [%] 11.93 2.24 0.88 0.57 0.63 
4 
Gold thickness [m] 0.567 0.108 0.055 0.036 0.040 
Threshold contrast [%] 7.36 1.43 0.75 0.49 0.62 
10 
Gold thickness [m] 0.716 0.125 0.060 0.030 0.040 
Threshold contrast [%] 9.17 1.69 0.82 0.41 0.55 
Table 8. The example of the golden objects thicknesses for particular diameters and 
corresponding values of threshold contrast values for unprocessed images for 
mammography units 2, 3, 4 and 10 (units 2, 3, 4 and 10 are the same as in Table 3).  
3.2 Contrast to noise ratio 
The contrast to noise ratio (CNR) is used for the evaluation of the functioning of the AEC 
systems (so called object thickness and tube voltage compensation) for a given 
mammography unit.  The functioning of the AEC systems should be controlled by 
exposures of PMMA plates of the thicknesses between 20 mm and 70 mm (10 mm step) with 
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clinical settings of the AEC (tube voltage, target, filter, mode and exposure control step). 
During these exposures the compression paddle should be maximally pressed against the 
top surface of the plates.  On the PMMA plates an aluminium object of 0.2 mm thickness 
should be placed.  The dimensions of the object should be large enough to be able to mark 
on the image an area of 4 cm2 as a region-of-interest (ROI). The PMMA plates have to cover 
the whole image detector.  In Fig. 5 the positioning of the aluminium object on the PMMA 
plates and the position of the ROI (for which the mean pixel value and standard deviation 
are calculated) is indicated.  
 
Fig. 5. The positioning of the aluminium object on PMMA plates and the ROI delineation for 
the CNR measurement. 
The contrast to noise ratio (CNR) parameter should be calculated for a particular object 
according to the below presented formula from the „European guidelines for quality 
assurance in breast cancer screening and diagnosis Fourth edition”: 
 
   
   2 2
2
mean pixel value signal mean pixel value background
CNR
Standard deviation signal Standard deviation background


  (5) 
where: 
mean pixel value (signal) - mean pixel value for the ROI in position 2; 
mean pixel value (background) - mean pixel value for ROI in position 1; 
standard deviation (signal) – standard deviation for ROI in position 2; 
standard deviation (background) – standard deviation for ROI in position 1. 
On the basis of these data the CNR should be calculated according to the formula (5) for 
every PMMA plate from 20 mm to 70 mm thickness.  The calculated CNR values should be 
referred to the limiting value (CNRlimiting value) calculated according to the formula (6) below: 
 100%/5
CNRiCNR =i cm CNRlimiting value
     (6)  
where: 
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CNR i/5 cm – CNR  value for PMMA plates of 20 mm, 30 mm, 40 mm, 45 mm, 50 mm, 60 mm 
and 70 mm thicknesses referred to the CNR value for PMMA phantom of 50 mm thickness; 
CNRi – CNR value determined for PMMA plates of 20 mm, 30 mm, 40 mm, 45 mm, 50 mm, 
60 mm and 70 mm thickness; 
CNR limiting value – the value calculated according to the formula (7) below; 
 
 
Tresholdcontrast CNRmeasured measuredCNR limiting value Treshold contrast limiting value
    (7) 
where: 
Threshold contrastmeasured – the value of the threshold contrast determined for the golden 
object of 0.1 mm diameter placed in PMMA 50 mm thick (determined according to the 
methodology presented in 3.1); 
CNRmeasured – CNR value determined for 50 mm PMMA; 
Threshold contrastlimiting value – limiting value of threshold contrast for a golden object of 0.1 
mm diameter, equal to 23%. 
According to the „European guidelines for quality assurance in breast cancer screening and 
diagnosis Fourth edition” the CNR values relative to the CNR for 50 mm PMMA must be 
determined during every control of the AEC system, at least every six month. The 
exemplary results for three mammography DR systems are presented in Table 9. In Table 9 
in the second column the limiting values are listed.  All results met the tolerance limits. The 
CNR values established for 70 mm PMMA thicknesses relative to the CNR for 50 mm 
PMMA were about 2 times higher (for every system) than the limiting value. In the case of 
20 mm PMMA it was larger than the limiting value by about 3 to 4 times (depending on the 
system). This means that the AEC system setting by the manufacturer service is done to 
meet the minimum manufacturer requirements without trying to reach maximum values. 
This leads to the increased exposure of the image detector without taking into account the 
fact that even with the lower exposure the CNR limiting requirements would be met.  
 
PMMA 
thickness 
[mm] 
CNR limiting value 
Unit 2 / 
Manufacturer 2  
Unit 3 / 
Manufacturer 2 
Unit 4/ 
Manufacturer 3 
CNR  relative to CNR for 50 mm PMMA [%] 
20  115 420 467 305 
30  110 388 415 266 
40  105 322 345 249 
45  103 298 308 252 
50  100 259 270 238 
60  95 192 214 225 
70  90 178 194 209 
Table 9. The limiting values of the CNR relative to the CNR value for 50 mm PMMA for the 
objects of different thicknesses („European guidelines for quality assurance in breast cancer 
screening and diagnosis Fourth edition”) and the exemplary results of CNR values relative 
to CNR for 50 mm PMMA for mammography units 2, 3 and 4 (units 2, 3 and 4 are the same 
as in Table 3). 
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3.3 Optimization 
The user of the mammography system 3 did not agree to make exposures at the AEC system 
setting other than Auto-filter mode. The only way to introduce changes in exposure 
parameters setting was selecting different (than these which were used at that moment) 
service settings of the unit. For this particular unit the manufacturer service could select one 
of the available AEC system modes named in the mammography unit documentation as 
“Table 0”, “Table 1”, “Table 2” and “Table 3” (Table 10). The manufacturer described the 
way in which the AEC system adapts the tube voltage value to the breast thickness after 
compression. Before the optimization attempt the “Table 0” mode was set, for which the 
clinical breast doses did not fulfil the acceptance criteria. It was necessary to find out for 
which setting the clinical breast doses could be lowered to the acceptance limits without 
affecting the threshold contrast and CNR for various PMMA plates thicknesses.  
For each AEC mode: 
 AGD values were calculated for typical breasts (described in 2.2 above); 
 evaluation of threshold contrast for discs of various diameters was performed 
(described in 3.1 above); 
 CNR values were determined for exposures of the PMMA plates of the thickness in the 
range from 20 mm to 70 mm (10 mm step) and for 45 mm (described in. 3.2 above). 
All these activities were carried out with the exposure control step set to “0”, in Auto-filter 
mode and with the main region of detector of the AEC system manually set closest to the 
chest wall. The results are presented in Table 11 and Table 12. In Table 11, the values of tube 
voltage, tube load and anode/filter combination selected by the AEC system for various 
thicknesses of PMMA plates, CNR relative to CNR for 50 mm PMMA and the AGD values 
calculated for typical breasts for four possible settings of the mammography unit 3, are 
given. In Table 12, the thicknesses of golden objects of various diameters and corresponding 
values of threshold contrast for four settings of the mammography unit 3, are presented. 
When comparing the values in Tables 11 and 12 with limiting levels given in Tables 2, 7 and 
9 one can see that quality criteria at the acceptable levels concerning all parameters (AGD, 
threshold contrast and CNR) are met for modes “Table 1”, “Table 2” and “Table 3” with the 
lowest clinical breast doses for mode “Table 3”. For this particular mammography unit all 
routine mammography examinations, before the optimization of exposure parameters, were 
performed with the “Table 0”. For this mode the clinical breast doses were the highest and 
for PMMA plates of 4.0 cm and 4.5 cm thickness the AGD values exceed slightly the 
acceptable level, but the image quality was the best of the four modes.  For the “Table 2” 
mode the image quality was the worst.  Out of remaining two modes, “Table 1” and “Table 
3”, the “Table 3” mode was selected because of the lower clinical breast doses.   
With the AEC setting in mode “Table 3” the mammography examinations were performed 
and the quality of the images was accepted by the radiologists. The “Table 3” mode was set 
by the manufacturer service as the permanent option not to be changed. The exposure 
control step (“0”) wasn’t changed. At these settings of the mammography unit the 
examinations of women have been started. For the examined women the clinical breast 
doses were calculated according to the methodology given in 2.3 above. In Table 13, the 
minimum, maximum and mean values of clinical breast doses calculated for the women 
examined with the use of the mammography unit 3 before and after the optimization of  
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Step 
# 
Thickness 
(cm) 
kV for 
“Table 0” 
kV for 
“Table 1” 
kV for 
“Table 2” 
kV for 
“Table 3” 
02 1.0 24 24 27 25 
03 1.5 24 24 27 25 
04 2.0 24 24 27 25 
05 2.5 24 24 27 26 
06 3.0 25 25 27 27 
07 3.5 26 25 28 28 
08 4.0 27 25 28 28 
09 4.5 28 26 28 29 
10 5.0 29 27 30 30 
11 5.5 30 28 31 30 
12 6.0 31 29 32 31 
13 6.5 32 29 32 31 
14 7.0 32 30 32 32 
15 7.5 32 31 33 32 
16 8.0 33 32 33 33 
17 8.5 33 33 33 33 
18 9.0 34 34 34 34 
19 9.5 34 34 35 34 
20 10.0 35 35 36 35 
21 10.5 35 35 37 36 
22 11.0 37 37 38 37 
23 11.5 38 38 39 38 
24 12.0 39 39 39 39 
25 12.5 39 39 39 39 
26 13.0 39 39 39 39 
27 13.5 39 39 39 39 
28 14.0 39 39 39 39 
29 14.5 39 39 39 39 
30 15.0 39 39 39 39 
31 15.5 39 39 39 39 
 
Table 10. Tube voltage selection scheme by the AEC system according to the breast thickness 
after compression – from technical documentation of the mammography unit 3. 
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Table 11. Tube voltage, tube load and anode/filter combination selected by the AEC system 
for PMMA plates of various thicknesses, CNR values relative to 5.0 cm PMMA and AGD 
values calculated for typical breasts for four operation modes of the AEC system for 
mammography unit 3. 
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Setting of 
AEC system 
Parameter 
Diameter of detail [mm] 
0.10 0.25 0.50 1.00 2.00 
“Table 0” 
Gold thickness  
[m] 0.525 0.125 0.068 0.030 0.040 
Threshold contrast 
[%] 
8.758 2.173 1.189 0.526 0.701 
“Table 1” 
Gold thickness  
[m] 0.547 0.134 0.060 0.030 0.040 
Threshold contrast 
[%] 
9.134 2.327 1.049 0.526 0.701 
“Table 2” 
Gold thickness  
[m] 0.753 0.138 0.081 0.037 0.040 
Threshold contrast 
[%] 
12.333 2.396 1.414 0.649 0.701 
“Table 3” 
Gold thickness  
[m] 0.806 0.143 0.056 0.036 0.040 
Threshold contrast 
[%] 
11.925 2.239 0.883 0.569 0.632 
Table 12. The thicknesses of golden objects of various diameters and corresponding values 
of threshold contrast for four settings of the AEC system for the mammography unit no 3. 
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Fig. 6. Clinical breast doses calculated for two groups of women examined with the 
mammography unit 3: before the optimization of exposure parameters (in black) and after 
the optimization (in grey). 
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Calculation of 
clinical breast doses 
Clinical breast doses [mGy] 
The percentage of exposures 
not exceeding 
minimum 
value 
maximum 
value 
mean 
value 
acceptable 
level 
achievable 
level 
Before the 
optimization 
2.45 7.71 3.89 1 % 0 % 
After the 
optimization 
1.16 3.64 1.80 80.5 % 47 % 
 
Table 13. Minimum, maximum and mean values of clinical breast doses calculated and the 
percentage of exposures, for which the clinical breast doses were below the acceptable and 
achievable level, before and after the optimization of exposure parameters for the 
mammography unit 3. 
exposure parameters, are presented. The percentage of exposures, for which the clinical 
breast dose values do not exceed the limiting values at the acceptable and achievable levels, 
are also given. The maximum, minimum and mean values of clinical breast doses after the 
optimization of exposure parameters were lower than these values before the optimization 
by about 53%. The values of clinical breast doses after the optimization of exposure 
parameters were below the acceptable level in 80.5% of cases and below the achievable level 
in 47% of cases. 
The decrease of the clinical breast dose values after setting the “Table 3” AEC mode on the 
mammography unit 3 is better presented in Fig. 6. Two histograms of clinical breast dose 
values, before the optimization of exposure parameters (in black) and after the optimization 
(in grey) are presented. They are clearly separated which means that the efforts to optimize 
the exposure parameters brought about a significant reduction of the clinical breast doses 
received by the women during examination. It should be noted that it was achieved at the 
cost of slight reduction of the visibility of the objects at the threshold contrast level, but it 
was accepted by the radiologists involved in image analysis in the mammography screening 
program. 
4. Conclusion 
The optimization procedure presented in this chapter is only a proposal of actions which 
could lead to the reduction of the doses received by the women during mammography 
examinations, especially in case of screening programs when probably healthy women are 
irradiated. The proposed approach has an advantage of not resigning of the system settings 
allowing for fully automatic of tube voltage and filter selection. Evidently, mammography 
units of various types and from different manufacturers have different capabilities but every 
capability should be first used for the optimization of exposure parameters and clinical 
breast doses reduction during mammography examinations.  
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